Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0043320110340060941
Archives of Pharmacal Research
2011 Volume.34 No. 6 p.941 ~ p.948
Encapsulation, pharmacokinetics and tissue distribution of interferon ¥á-2b liposomes after intramuscular injection to rats
Li Hao

Yang Li
Cheng Gang
Wei Hong Yan
Zeng Qun
Abstract
The aim of the present study was to investigate the effect of liposome-encapsulation and liposome-size on the in vivo pharmacokinetics of interferon ¥á-2b (IFN¥á-2b) following i.m. administration to rats, and whether there was any liver-targeting of these liposomes. Since liposomes of different sizes can be obtained by homogenization, the effect of homogenization on the IFN¥á-2b activity was also investigated. The pharmacokinetics of IFN¥á-2b solution (12.8 ¥ìg/kg) and IFN¥á-2b prepared in liposomes, including three mean sizes of 172 nm (12.2¥ìg/kg), 113 nm (44.2, 11.0, and 2.8¥ìg/kg, respectively), and 82 nm (13.1 ¥ìg/kg), were studied after a single i.m. dose to rats. Compared to a solution of IFN¥á-2b. administration of liposomal IFN¥á-2b resulted in a significantly prolonged tmax, the apparent elimination half life (t1/2¥â) was 2.3 times longer, both AUC0-¡Ä and MRT0-¡Ä were also clearly enhanced and greater accumulation was obtained in the liver (p < 0.05). The AUC0-¡Ä increased proportionally to the administered dose of IFN¥á-2b liposomes. Moreover, the size of liposomes ranging from 82 nm to 172 nm had no significant difference on the pharmacokinetic behavior in vivo (p > 0.05). In sum, compared with the free form, IFN¥á-2b encapsulated in liposomes can alter strikingly the pharmacokinetics properties following i.m. injection and if a liposomal size ranging from 82 nm to 172 nm was used, consistent pharmacokinetic behaviors of IFN¥á-2b was exhibited. The liposomal formulation apparently targeted the liver, offering a potential advantage for hepatitis B treatment.
KEYWORD
IFN¥á-2b, Liposomes, Pharmacokinetics, Tissue distribution, Liposomal siz
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)